Home
Pharmaceuticals Samarra proceed with the implementation of the second phase of the project life production of antibiotics
10/15/2015
(Independent) .. General Company for the manufacture of medicines and medical supplies began in Samarra, one of the Ministry of Industry and Minerals implementation of the second phase of the project life production of pharmaceutical antibiotics all get their own identity.
The general director of the company Falah Hassan Saleh, said that the project is a separate manufacturers for the production of all kinds of life antibiotics such as penicillins and Sifsborenat in addition to the production of sterile cephalosporin up where the need for Iraq from Almakh injections to nearly 40 million annually Vial.
He noted that the project, which consists of two buildings established on an area of land estimated at 10,000 square meters with a single factory space with services (4,000) square meters, announcing that the work currently done by 40%.
The company also completed the tender for the project import equipment, which will be processed under the supervision of a German company, pointing out that it continues the implementation of the project and the completion of the remaining works, including internal and external works Kalqguata Clalakopon and Foreign brick streets, lighting, park and parking.
Saleh pointed out that this project is of strategic projects important for the country and the large economic returns and will contribute to provide an opportunity for the company to cooperate with international companies require GMP rules for the production of CO-AMOXICLAV in the form of pills or suspensions.
[You must be registered and logged in to see this link.]
10/15/2015
(Independent) .. General Company for the manufacture of medicines and medical supplies began in Samarra, one of the Ministry of Industry and Minerals implementation of the second phase of the project life production of pharmaceutical antibiotics all get their own identity.
The general director of the company Falah Hassan Saleh, said that the project is a separate manufacturers for the production of all kinds of life antibiotics such as penicillins and Sifsborenat in addition to the production of sterile cephalosporin up where the need for Iraq from Almakh injections to nearly 40 million annually Vial.
He noted that the project, which consists of two buildings established on an area of land estimated at 10,000 square meters with a single factory space with services (4,000) square meters, announcing that the work currently done by 40%.
The company also completed the tender for the project import equipment, which will be processed under the supervision of a German company, pointing out that it continues the implementation of the project and the completion of the remaining works, including internal and external works Kalqguata Clalakopon and Foreign brick streets, lighting, park and parking.
Saleh pointed out that this project is of strategic projects important for the country and the large economic returns and will contribute to provide an opportunity for the company to cooperate with international companies require GMP rules for the production of CO-AMOXICLAV in the form of pills or suspensions.
[You must be registered and logged in to see this link.]
